BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 15080903)

  • 21. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
    Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.
    Bolognesi ML; Bartolini M; Cavalli A; Andrisano V; Rosini M; Minarini A; Melchiorre C
    J Med Chem; 2004 Nov; 47(24):5945-52. PubMed ID: 15537349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Docking and quantum mechanic studies on cholinesterases and their inhibitors.
    Correa-Basurto J; Flores-Sandoval C; Marín-Cruz J; Rojo-Domínguez A; Espinoza-Fonseca LM; Trujillo-Ferrara JG
    Eur J Med Chem; 2007 Jan; 42(1):10-9. PubMed ID: 17055616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of 4-[(diethylamino)methyl]-phenol derivatives as novel cholinesterase inhibitors with selectivity towards butyrylcholinesterase.
    Yu L; Cao R; Yi W; Yan Q; Chen Z; Ma L; Peng W; Song H
    Bioorg Med Chem Lett; 2010 Jun; 20(11):3254-8. PubMed ID: 20452769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase.
    Darvesh S; Darvesh KV; McDonald RS; Mataija D; Walsh R; Mothana S; Lockridge O; Martin E
    J Med Chem; 2008 Jul; 51(14):4200-12. PubMed ID: 18570368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular dynamics simulation of Axillaridine-A: a potent natural cholinesterase inhibitor.
    ul-Haq Z; Hadi H; Moin ST; Choudhary MI
    J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1101-5. PubMed ID: 19555175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and evaluation of novel rutaecarpine derivatives and related alkaloids derivatives as selective acetylcholinesterase inhibitors.
    Wang B; Mai YC; Li Y; Hou JQ; Huang SL; Ou TM; Tan JH; An LK; Li D; Gu LQ; Huang ZS
    Eur J Med Chem; 2010 Apr; 45(4):1415-23. PubMed ID: 20079560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, biological activity, and docking studies of new acetylcholinesterase inhibitors of the bispyridinium type.
    Kapková P; Stiefl N; Sürig U; Engels B; Baumann K; Holzgrabe U
    Arch Pharm (Weinheim); 2003 Nov; 336(11):523-40. PubMed ID: 14639745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New pregnane-type steroidal alkaloids from Sarcocca saligna and their cholinesterase inhibitory activity.
    Atta-ur-Rahman ; Feroz F; Naeem I; Zaheer-ul-Haq ; Nawaz SA; Khan N; Khan MR; Choudhary MI
    Steroids; 2004; 69(11-12):735-41. PubMed ID: 15685740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-activity studies on acetylcholinesterase inhibition in the lycorine series of Amaryllidaceae alkaloids.
    McNulty J; Nair JJ; Little JR; Brennan JD; Bastida J
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5290-4. PubMed ID: 20655219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Derivatives of oxoisoaporphine alkaloids: a novel class of selective acetylcholinesterase inhibitors.
    Tang H; Ning FX; Wei YB; Huang SL; Huang ZS; Chan AS; Gu LQ
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3765-8. PubMed ID: 17451950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CNS-selective noncompetitive cholinesterase inhibitors derived from the natural piperidine alkaloid (-)-spectaline.
    Castro NG; Costa RS; Pimentel LS; Danuello A; Romeiro NC; Viegas C; Barreiro EJ; Fraga CA; Bolzani VS; Rocha MS
    Eur J Pharmacol; 2008 Feb; 580(3):339-49. PubMed ID: 18096154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel tricyclic quinazolinimines and related tetracyclic nitrogen bridgehead compounds as cholinesterase inhibitors with selectivity towards butyrylcholinesterase.
    Decker M; Krauth F; Lehmann J
    Bioorg Med Chem; 2006 Mar; 14(6):1966-77. PubMed ID: 16289855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The oxidation products of melatonin derivatives exhibit acetylcholinesterase and butyrylcholinesterase inhibitory activity.
    Siwicka A; Moleda Z; Wojtasiewicz K; Zawadzka A; Maurin JK; Panasiewicz M; Pacuszka T; Czarnocki Z
    J Pineal Res; 2008 Aug; 45(1):40-9. PubMed ID: 18284552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Steroidal alkaloids from Holarrhena antidysenterica as acetylcholinesterase inhibitors and the investigation for structure-activity relationships.
    Yang ZD; Duan DZ; Xue WW; Yao XJ; Li S
    Life Sci; 2012 Jun; 90(23-24):929-33. PubMed ID: 22569298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, characterization, oxidative degradation, antibacterial activity and acetylcholinesterase/butyrylcholinesterase inhibitory effects of some new phosphorus(V) hydrazides.
    Gholivand K; Hosseini Z; Farshadian S; Naderi-Manesh H
    Eur J Med Chem; 2010 Nov; 45(11):5130-9. PubMed ID: 20801550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine.
    Tumiatti V; Rosini M; Bartolini M; Cavalli A; Marucci G; Andrisano V; Angeli P; Banzi R; Minarini A; Recanatini M; Melchiorre C
    J Med Chem; 2003 Mar; 46(6):954-66. PubMed ID: 12620072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage--implications for early Myasthenia gravis treatment.
    Musilek K; Komloova M; Holas O; Hrabinova M; Pohanka M; Dohnal V; Nachon F; Dolezal M; Kuca K
    Eur J Med Chem; 2011 Feb; 46(2):811-8. PubMed ID: 21236521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
    Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y
    Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Berberine derivatives, with substituted amino groups linked at the 9-position, as inhibitors of acetylcholinesterase/butyrylcholinesterase.
    Huang L; Luo Z; He F; Shi A; Qin F; Li X
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6649-52. PubMed ID: 20880702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.